Drug Shortage Report for SANDOZ AMBRISENTAN TABLETS
Report ID | 218454 |
Drug Identification Number | 02526883 |
Brand name | SANDOZ AMBRISENTAN TABLETS |
Common or Proper name | AMBRISENTAN TABLETS |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | AMBRISENTAN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 10MG 30FCT |
ATC code | C02KX |
ATC description | OTHER ANTIHYPERTENSIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-05 |
Estimated end date | 2024-04-19 |
Actual end date | 2024-04-23 |
Shortage status | Resolved |
Updated date | 2024-04-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-02-05 | English | Compare |
v2 | 2024-02-05 | French | Compare |
v3 | 2024-02-06 | English | Compare |
v4 | 2024-02-12 | English | Compare |
v5 | 2024-02-12 | French | Compare |
v6 | 2024-02-19 | English | Compare |
v7 | 2024-02-19 | French | Compare |
v8 | 2024-03-05 | English | Compare |
v9 | 2024-03-05 | French | Compare |
v10 | 2024-03-18 | English | Compare |
v11 | 2024-03-18 | French | Compare |
v12 | 2024-04-02 | English | Compare |
v13 | 2024-04-02 | French | Compare |
v14 | 2024-04-16 | English | Compare |
v15 | 2024-04-16 | French | Compare |
v16 | 2024-04-23 | English | Compare |
v17 | 2024-04-23 | French | Compare |
v18 | 2024-04-24 | English | Compare |
Showing 1 to 18 of 18